New "Cure4Cancer" Hub Launched to Raise Awareness of International Clinical Trials | Asia Society Skip to main content

Unsupported Browser Detected.
It seems the web browser you're using doesn't support some of the features of this site. For the best experience, we recommend using a modern browser that supports the features of this website. We recommend Google Chrome, Mozilla Firefox, or Microsoft Edge

  • Policy
    • Asia Society Policy Institute
      • Center for China Analysis
      • Topics
      • Countries & Regions
      • Publications
      • Initiatives
      • Watch & Listen
      • Events
      • About
      • Support Us
    • Center on U.S.-China Relations
      • Home
      • About
      • Projects
      • Events
      • Reports
      • COAL + ICE
      • ChinaFile
  • Arts
    • Arts & Culture
      • Film
      • Literature
      • Performing Arts
    • Asia Society Museum
      • Visit
      • Exhibitions
      • Programs
      • Collection
      • Asia Society Triennial
      • The Asia Arts and Museum Network
      • Learn
    • Asia Arts Game Changer Awards
      • About
      • Honorees
      • Ceremonies
      • Photos
      • Support
    • Creative Voices of Muslim Asia
      • Resources
      • Exhibitions
      • Videos
  • Education
    • Chinese Language Learning
    • Global Education
    • Discover Asia
    • About
  • Initiatives
    • Arts
      • Arts & Museum Summit
      • Asia Arts Game Changer Awards
      • Asia Society Museum: The Asia Arts & Museum Network
      • Creative Voices of Muslim Asia
      • U.S.-China Museum Summit
      • U.S.-Asia Entertainment Summit
    • Leadership
      • Asia Game Changer Awards
      • Asia 21 Next Generation Fellows
      • Diversity Leadership Initiatives
      • U.S.-China Dialogue
    • Policy
      • Asia Society Policy Institute
      • Center on U.S.-China Relations
    • Sustainability
      • Asia Society Policy Institute
      • Coal + Ice
  • Countries & Regions
    • Column One
      • Afghanistan
      • American Samoa
      • Armenia
      • Australia
      • Azerbaijan
      • Bahrain
      • Bangladesh
      • Bhutan
      • Brunei
      • Cambodia
      • Central Asia
      • China
      • Cook Islands

      • Cyprus
      • East Asia
      • East Timor
      • Fiji
      • French Polynesia
      • Georgia
      • Guam
    • Column Two
      • Hong Kong
      • India
      • Indonesia
      • Iran
      • Iraq
      • Israel
      • Japan
      • Jordan
      • Kazakhstan
      • Kiribati
      • Kuwait
      • Kyrgyzstan
      • Laos
      • Lebanon
      • Macau
      • Malaysia
      • Maldives
      • Marshall Islands
      • Micronesia
      • Mongolia
    • Column Three
      • Myanmar
      • Nauru
      • Nepal
      • New Caledonia
      • New Zealand
      • Niue
      • North Korea
      • Northern Marianas
      • Oceania
      • Oman
      • Pakistan
      • Palau
      • Palestine
      • Papua New Guinea
      • Philippines
      • Qatar
      • Samoa
      • Saudi Arabia
      • Singapore
      • Solomon Islands
    • Column Four
      • South Asia
      • Southeast Asia
      • South Korea
      • Sri Lanka
      • Syria
      • Taiwan
      • Tajikistan
      • Thailand
      • Tibet
      • Tokelau
      • Tonga
      • Turkey
      • Turkmenistan
      • Tuvalu
      • United Arab Emirates
      • Uzbekistan
      • Vanuatu
      • Vietnam
      • Wallis and Futuna
      • West Asia
      • Yemen
  • Current Affairs
    • Topics
      • Business
      • Climate Change
      • Governance
    • Programming
      • Beyond the Headlines
      • Business of Asia
    • Center on U.S.-China Relations
      • Home
      • About
      • Projects
      • Reports
      • Past Events
      • ChinaFile
  • Look & Listen
    • Asia Society Magazine
    • ChinaFile
    • Podcasts
    • Video Gallery
  • Events
    • Upcoming Events
    • Past Events
  • Visit
    • Visit Us
      • Hong Kong
      • New York
      • Texas
    • Global Network
      • Australia
      • France
      • India
      • Japan
      • Korea
      • Northern California
      • Philippines
      • Southern California
      • Switzerland
      • Washington, D.C.
  • About
    • About Asia Society
    • Inclusion & Diversity
    • Background & History
    • Board of Trustees
    • Senior Leadership
    • Global Staff
    • Global Council
    • Careers
    • Interns and Volunteers
    • Financial Statements
    • For the Media
      • Press Releases
  • Support
    • The Campaign for Asia Society
    • Corporate Engagement
      • Business Council
      • Technology and Innovation Council
      • Global Talent and Diversity Council
      • Rising Executives Network
      • Enhancements to Membership
      • Corporate Membership
      • Global Corporate Leaders
    • Membership
    • Donate
    • Donor Privacy Statement
Subscribe
Search
  • Policy
    • Asia Society Policy Institute
      • Center for China Analysis
      • Topics
      • Countries & Regions
      • Publications
      • Initiatives
      • Watch & Listen
      • Events
      • About
      • Support Us
    • Center on U.S.-China Relations
      • Home
      • About
      • Projects
      • Events
      • Reports
      • COAL + ICE
      • ChinaFile
  • Arts
    • Arts & Culture
      • Film
      • Literature
      • Performing Arts
    • Asia Society Museum
      • Visit
      • Exhibitions
      • Programs
      • Collection
      • Asia Society Triennial
      • The Asia Arts and Museum Network
      • Learn
    • Asia Arts Game Changer Awards
      • About
      • Honorees
      • Ceremonies
      • Photos
      • Support
    • Creative Voices of Muslim Asia
      • Resources
      • Exhibitions
      • Videos
  • Education
    • Chinese Language Learning
    • Global Education
    • Discover Asia
    • About
  • Initiatives
    • Arts
      • Arts & Museum Summit
      • Asia Arts Game Changer Awards
      • Asia Society Museum: The Asia Arts & Museum Network
      • Creative Voices of Muslim Asia
      • U.S.-China Museum Summit
      • U.S.-Asia Entertainment Summit
    • Leadership
      • Asia Game Changer Awards
      • Asia 21 Next Generation Fellows
      • Diversity Leadership Initiatives
      • U.S.-China Dialogue
    • Policy
      • Asia Society Policy Institute
      • Center on U.S.-China Relations
    • Sustainability
      • Asia Society Policy Institute
      • Coal + Ice
  • Countries & Regions
    • Column One
      • Afghanistan
      • American Samoa
      • Armenia
      • Australia
      • Azerbaijan
      • Bahrain
      • Bangladesh
      • Bhutan
      • Brunei
      • Cambodia
      • Central Asia
      • China
      • Cook Islands

      • Cyprus
      • East Asia
      • East Timor
      • Fiji
      • French Polynesia
      • Georgia
      • Guam
    • Column Two
      • Hong Kong
      • India
      • Indonesia
      • Iran
      • Iraq
      • Israel
      • Japan
      • Jordan
      • Kazakhstan
      • Kiribati
      • Kuwait
      • Kyrgyzstan
      • Laos
      • Lebanon
      • Macau
      • Malaysia
      • Maldives
      • Marshall Islands
      • Micronesia
      • Mongolia
    • Column Three
      • Myanmar
      • Nauru
      • Nepal
      • New Caledonia
      • New Zealand
      • Niue
      • North Korea
      • Northern Marianas
      • Oceania
      • Oman
      • Pakistan
      • Palau
      • Palestine
      • Papua New Guinea
      • Philippines
      • Qatar
      • Samoa
      • Saudi Arabia
      • Singapore
      • Solomon Islands
    • Column Four
      • South Asia
      • Southeast Asia
      • South Korea
      • Sri Lanka
      • Syria
      • Taiwan
      • Tajikistan
      • Thailand
      • Tibet
      • Tokelau
      • Tonga
      • Turkey
      • Turkmenistan
      • Tuvalu
      • United Arab Emirates
      • Uzbekistan
      • Vanuatu
      • Vietnam
      • Wallis and Futuna
      • West Asia
      • Yemen
  • Current Affairs
    • Topics
      • Business
      • Climate Change
      • Governance
    • Programming
      • Beyond the Headlines
      • Business of Asia
    • Center on U.S.-China Relations
      • Home
      • About
      • Projects
      • Reports
      • Past Events
      • ChinaFile
  • Look & Listen
    • Asia Society Magazine
    • ChinaFile
    • Podcasts
    • Video Gallery
  • Events
    • Upcoming Events
    • Past Events
  • Visit
    • Visit Us
      • Hong Kong
      • New York
      • Texas
    • Global Network
      • Australia
      • France
      • India
      • Japan
      • Korea
      • Northern California
      • Philippines
      • Southern California
      • Switzerland
      • Washington, D.C.
  • About
    • About Asia Society
    • Inclusion & Diversity
    • Background & History
    • Board of Trustees
    • Senior Leadership
    • Global Staff
    • Global Council
    • Careers
    • Interns and Volunteers
    • Financial Statements
    • For the Media
      • Press Releases
  • Support
    • The Campaign for Asia Society
    • Corporate Engagement
      • Business Council
      • Technology and Innovation Council
      • Global Talent and Diversity Council
      • Rising Executives Network
      • Enhancements to Membership
      • Corporate Membership
      • Global Corporate Leaders
    • Membership
    • Donate
    • Donor Privacy Statement

New "Cure4Cancer" Hub Launched to Raise Awareness of International Clinical Trials

Cure4Cancer homepage

NEW YORK, March 6, 2023 — The Asia Society Policy Institute (ASPI), in collaboration with Memorial Sloan Kettering Cancer Center (MSK), Bloomberg New Economy International Cancer Coalition, and others have jointly launched Cure4Cancer (C4C), a new online informational hub to raise public awareness about international clinical trials and their unique capacity to extend, improve, and save lives. The new site cure4cancerglobal.org is the first portal of its kind bringing together information about international collaboration on clinical trials and regulatory harmonization.

Scientifically, a primary barrier to finding life-saving new cancer treatments or prevention is the time it takes to conduct clinical trials. Over 19 million new cancer cases are diagnosed worldwide every year, but only less than 5% enroll in clinical trials, despite the fact that clinical trials are widely recognized by clinical practice guidelines as the best treatment for patients with cancer. This is often due to a lack of patient awareness or understanding of clinical trials and their major advantages, such as access to the most advanced treatments and monitoring.

Bureaucratic red tape and a lack of coordination between government regulatory agencies in different countries also limit clinical trials and patient access to innovative treatments. The international standardization of clinical trials and concurrent approvals has proven capable of shortening the time needed to roll out a new cancer treatment from 15 years to two or three years. Better standardization could help 10% of all cancer patients reduce their risk of death by 10% to 20% annually, representing one to two million lives saved every year.

ASPI and MSK have worked together since 2017 to address these barriers through international policy research, public awareness, and private diplomacy. The new C4C website, its most significant public-facing contribution to-date, brings together key information for the public about patients’ personal journeys with clinical trials, how to find and join a study, perspectives from physicians and other leaders around the world, the history of international clinical trials collaboration, and milestones from a global public health policy perspective.

While China and the U.S. account for almost 40% of the world’s 10 million annual cancer deaths, no country or region is spared, and the global cancer burden is expected to increase. To fight this common enemy of humanity, greater international collaboration on cancer clinical trials is required. C4C is an international movement that brings together patients, clinicians, scientists, policymakers, regulators, industry, philanthropy, the media, and other closely related stakeholders to work together in the global fight against cancer. All are welcome to join in the effort to accelerate the Cure4Cancer in this lifetime.

Asia Society President and CEO and the 26th Prime Minister of Australia, the Hon. Dr. Kevin Rudd said: “To accelerate the eradication of cancer globally, we need multi-stakeholder, multi-regional collaboration which brings together academia, industry, government, patient advocacy and policy think tanks from different regions for collective action to promote both patient-centric clinical trials and international regulatory harmonization. This would not only provide global public goods by building the policy, scientific and technological infrastructure for international public health collaboration, but could also become the new ping-pong diplomacy between the U.S. and China, bringing some stabilizing and positive force for the bilateral relationship and beyond.”

Dr. Bob Li, Medical Oncologist and Physician Ambassador to China and Asia-Pacific at Memorial Sloan Kettering Cancer Center; Senior Fellow on Global Public Health at the Asia Society Policy Institute’s Center for China Analysis, said: “Clinical trials are the critical step of translating scientific discovery into saving lives. It currently takes on average 10 to 15 years to develop any new therapeutics because we work in silos and simply can’t find the right patients in need for the right treatment. We have now done proof of concept to show that we can lead these breakthroughs in a much quicker time frame of 2-3 years [if] we all work together to break down the silos in a multiregional, international fashion. If we do this at scale – if everybody’s doing international trials, getting them through regulatory agencies, having governments work together from the outset and through the approval process – we can really bring lifesaving innovation to more patients in need much faster.”

Jing Qian, Co-Founder and Managing Director of the Asia Society Policy Institute’s Center for China Analysis, said: “Cancer is a common, transnational enemy of humanity, but it can be fixed. Better international coordination and harmonization of cancer clinical trials could save as many as two million lives every single year. A core part of our international Cure4Cancer movement is to raise public awareness of the extremely undervalued potential of international clinical trials and in turn to open up more political space, empower more policy innovations and promote patient-centric treatments globally. Hopefully in the end we can improve the lives of the millions of patients and families suffering from cancer, and accelerate the cure for cancer for the whole of humanity.”

To speak with Jing Qian or any of our other experts at Asia Society Policy Institute please reach out to pr@asiasociety.org. To speak with Dr. Bob Li at Memorial Sloan Kettering Cancer Center, please reach out to williamr@mskcc.org.

About
  • Mission & History
  • Our People
  • Become a Member
  • Career Opportunities
  • Corporate Involvement
visit us
  • Hong Kong
  • New York
  • Texas
global network
  • Australia
  • France
  • India
  • Japan
  • Korea
  • Northern California
  • Philippines
  • Southern California
  • Switzerland
  • Washington, D.C.
resources
  • Arts
  • Asia Society Magazine
  • ChinaFile
  • Current Affairs
  • Education
  • For Kids
  • Policy
  • Video
shop
  • AsiaStore
initiatives
  • Arts & Museum Summit
  • Asia 21 Next Generation Fellows
  • Asia Arts Game Changer Awards
  • Asia Game Changer Awards
  • Asia Society Museum: The Asia Arts & Museum Network
  • Asia Society Policy Institute
  • Asian Women Empowered
  • Center on U.S.-China Relations
  • Coal + Ice
  • Creative Voices of Muslim Asia
  • Global Cities Education Network
  • Global Talent Initiatives
  • U.S.-Asia Entertainment Summit
  • U.S.-China Dialogue
  • U.S.-China Museum Summit
Connect
Email Signup For the media
Asia Society logo
©2023 Asia Society | Privacy Statement | Accessibility | Terms & Conditions | Sitemap | Contact

Asia Society takes no institutional position on policy issues and has no affiliation with any government.
The views expressed by Asia Society staff, fellows, experts, report authors, program speakers, board members, and other affiliates are solely their own. Learn more.

 

 

  • Visit Us
  • Hong Kong
  • New York
  • Texas
  • Global Network
  • Australia
  • France
  • India
  • Japan
  • Korea
  • Northern California
  • Philippines
  • Southern California
  • Switzerland
  • Washington, DC